130 related articles for article (PubMed ID: 8575691)
1. Influence of menopause on the cell kinetics of normal, hyperplastic, and malignant endometrium.
Ishihara H; Itamochi H
Gynecol Obstet Invest; 1995; 40(2):129-32. PubMed ID: 8575691
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometry of normal, hyperplastic, and malignant human endometrium. A study of ploidy and proliferative indices including comparison with in vitro S-phase labeling.
Thornton JG; Quirke P; Wells M
Am J Obstet Gynecol; 1989 Aug; 161(2):487-92. PubMed ID: 2475021
[TBL] [Abstract][Full Text] [Related]
3. [Proliferative activity of normal endometrial cells, endometrial hyperplasia cells and endometrial cancer cells using the monoclonal antibody to PCNA].
Hareyama H
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1427-1. PubMed ID: 7705752
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric DNA analysis of abnormal endometrium.
Sato S; Tanoguchi K; Tase T; Yajima A
Tohoku J Exp Med; 1996 Feb; 178(2):199-202. PubMed ID: 8727701
[TBL] [Abstract][Full Text] [Related]
5. [Contribution of immunohistochemistry and flow-cytometry in the study of endometrial pathology].
Amălinei C; Căruntu ID; Balan R; Cianga C; Cianga P
Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):437-48. PubMed ID: 19295017
[TBL] [Abstract][Full Text] [Related]
6. Patterns of immunohistochemical staining for proliferating cell nuclear antigen and p53 in benign and neoplastic human endometrium.
Yu CC; Wilkinson N; Brito MJ; Buckley CH; Fox H; Levison DA
Histopathology; 1993 Oct; 23(4):367-71. PubMed ID: 7905459
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric cell cycle kinetics and quantitative measurement of c-erbB-2 and mutant p53 proteins in normal, hyperplastic, and malignant endometrial biopsies.
Eissa S; Abu Saada M; el-Sharkawy T
Clin Biochem; 1997 Apr; 30(3):209-14. PubMed ID: 9167896
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of heat shock protein 27, in normal hyperplastic and neoplastic endometrium: correlation with estrogen and progesterone receptor status, p53, pRb and proliferation associated indices (PCNA, MIB1).
Zagorianakou N; Ioachim E; Mitselou A; Kitsou E; Zagorianakou P; Makrydimas G; Salmas M; Agnantis NJ
Eur J Gynaecol Oncol; 2003; 24(3-4):299-304. PubMed ID: 12807244
[TBL] [Abstract][Full Text] [Related]
10. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of the PCNA and P53 proteins expression in the proliferative, hyperplastic and neoplastic human endometrium].
Zawiślak W; Semczuk A; Miturski R
Ginekol Pol; 2001 Dec; 72(12A):1549-54. PubMed ID: 11883313
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of cell surface antigen recognized by monoclonal antibody (MSN-1) in normal, hyperplasia, and carcinoma of endometrial cells: its diagnostic value for endometrial carcinoma.
Kobayashi Y; Tsukazaki K; Ohta K; Mikami M; Kubushiro K; Nozawa S
Cytometry; 1997 Feb; 30(1):23-7. PubMed ID: 9056738
[TBL] [Abstract][Full Text] [Related]
14. Immunohistological localization of tenascin in the human endometrium.
Yamanaka M; Taga M; Minaguchi H
Gynecol Obstet Invest; 1996; 41(4):247-52. PubMed ID: 8793495
[TBL] [Abstract][Full Text] [Related]
15. Thickened endometrium in the postmenopausal woman: sonographic-pathologic correlation.
Sheth S; Hamper UM; Kurman RJ
Radiology; 1993 Apr; 187(1):135-9. PubMed ID: 8451399
[TBL] [Abstract][Full Text] [Related]
16. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
[TBL] [Abstract][Full Text] [Related]
17. [Suitability of metric structural criteria in vaginal ultrasound assessment of the postmenopausal endometrium].
Weigel M; Schmitt W; Melchert F
Zentralbl Gynakol; 1992; 114(8):420-4. PubMed ID: 1519402
[TBL] [Abstract][Full Text] [Related]
18. Expression of Laminin Receptor 1 in Normal, Hyperplastic, and Malignant Endometrium.
Kurdoglu M; Kucukaydin Z; Kurdoglu Z; Bulut G; Unlu Y; Ozen S
Int J Gynecol Pathol; 2019 Jul; 38(4):326-334. PubMed ID: 30028353
[TBL] [Abstract][Full Text] [Related]
19. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data.
Agorastos T; Bontis J; Vakiani A; Vavilis D; Constantinidis T
Gynecol Oncol; 1997 Apr; 65(1):102-14. PubMed ID: 9103399
[TBL] [Abstract][Full Text] [Related]
20. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
